tiprankstipranks
Larimar Therapeutics, Inc. (LRMR)
NASDAQ:LRMR
US Market
LRMR
Larimar Therapeutics
RESEARCH TOOLSreports
Want to see LRMR full AI Analyst Report?

Larimar Therapeutics (LRMR) Income Statement

1,104 Followers

Larimar Therapeutics Income Statement

Last quarter (Q4 2025), Larimar Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Larimar Therapeutics's net income was $-62.50M. See Larimar Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -350.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 172.50M$ 90.89M$ 41.76M$ 36.53M$ 50.47M
Depreciation and Amortization
$ 350.00K$ 318.00K$ 311.00K$ 318.00K$ 326.00K
EBITDA
$ -172.50M$ -90.57M$ -41.45M$ -36.21M$ -50.14M
Operating Income
$ -172.50M$ -90.89M$ -41.76M$ -36.53M$ -50.47M
Other Income/Expenses
$ 6.82M$ 10.29M$ 4.81M$ 1.17M$ -171.00K
Pretax Income
$ -165.67M$ -80.60M$ -36.95M$ -35.35M$ -50.64M
Net Income
$ -165.67M$ -80.60M$ -36.95M$ -35.35M$ -50.64M
Per Share Metrics
Basic EPS
$ -2.27$ -1.32$ -0.84$ -1.33$ -2.93
Diluted EPS
$ -2.27$ -1.32$ -0.84$ -1.33$ -2.93
Weighted Average Shares Outstanding
 72.95M 61.26M 43.90M 25.76M 17.16M
Weighted Average Shares Outstanding (Diluted)
 72.95M 61.26M 43.90M 25.76M 17.16M
Currency in USD

Larimar Therapeutics Earnings and Revenue History